Welcome to our dedicated page for Bioceres Crop Solutions SEC filings (Ticker: BIOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bioceres Crop Solutions Corp. (NASDAQ: BIOX) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Bioceres files annual reports on Form 20-F and frequent current reports on Form 6-K, presenting financial statements in accordance with International Financial Reporting Standards (IFRS) and expressing figures in U.S. dollars.
Through these filings, readers can review segment-level financial information for Bioceres’ Crop Protection, Seed and Integrated Products, and Crop Nutrition businesses, along with consolidated statements of comprehensive income, financial position and cash flows. The documents also discuss non-IFRS measures such as Adjusted EBITDA and provide reconciliations and explanations referenced in the company’s earnings releases.
Bioceres’ Form 6-K submissions include earnings press releases for quarterly and full-year periods, subsidiary financial statements, and materials for its Annual General Meeting, such as notices and proxy documents. Other 6-Ks describe governance and management changes, including appointments and resignations of directors and executives, and the designation of a principal accounting officer.
The filings also detail financing arrangements and legal matters, such as secured and convertible note purchase agreements, corporate bonds and amendments to these instruments. In a November 2025 Form 6-K, Bioceres reported receiving a Declaration of Acceleration of Notes from certain noteholders and disclosed related litigation, while stating that it disputes the alleged defaults and intends to defend its position.
On Stock Titan, these SEC filings are updated as they are released on EDGAR, and AI-powered tools can be used to summarize lengthy documents, highlight key segment data, and help readers quickly locate information on topics such as revenue composition, debt instruments, equity structure and governance disclosures.
Bioceres Crop Solutions Corp. (BIOX) reported leadership changes. Effective November 5, 2025, the Board appointed Simon Vumbaca as a director. The company describes him as a multi‑jurisdictional lawyer focused on cross‑border structuring, geopolitical strategy, and crisis arbitration, who advises sovereigns, ultra‑high‑net‑worth families, and global enterprises; he chairs AIG’s Board and serves as a non‑executive director of Elemental Altus.
Also effective November 5, 2025, the Board named Alejandro Villafane as Principal Accounting Officer, formalizing oversight for the company’s accounting function.
Bioceres Crop Solutions Corp. reported a governance change, noting that board member Scott Crocco resigned from the company’s board of directors effective October 10, 2025. The filing states only the fact and effective date of his departure, without describing any related circumstances or strategic changes. The report is also designated to be incorporated by reference into the company’s existing Form F-3 and Form S-8 registration statements.
Bioceres Crop Solutions Corp. reports that Noah Kolatch resigned from its board of directors effective September 30, 2025. His resignation is linked to a reservation of rights letter sent to the company by Jasper Lake through counsel on September 25, 2025, which raised issues under existing Note Purchase Agreements. The company responded on September 30, 2025 with its own reservation of rights letter, disputing that any Events of Default have occurred and expressing its view that constructive dialogue with Jasper Lake is in the best interests of the company and its stakeholders. Bioceres states that it remains focused on improving its commercial and financial performance and on delivering innovative agricultural solutions.
Bioceres Crop Solutions Corp. received an Amendment No. 1 to a Schedule 13D filed by Jasper Lake Ventures One LLC and Noah Kolatch reporting a combined beneficial position of 7,482,961 ordinary shares, representing approximately 10.7% of outstanding shares on a diluted basis. The reported amount includes 397,000 shares held directly and 7,085,961 shares issuable upon conversion of notes convertible within 60 days. Jasper Lake notified the issuer on September 25, 2025 that it believes certain Events of Default under a Note Purchase Agreement have occurred and reserved all rights; the issuer disputes that claim. In connection with this dispute, Mr. Kolatch resigned from the issuer's board effective September 30, 2025. The filing otherwise restates ownership, voting/dispositive powers (shared) and confirms no transactions in the prior 60 days.
Bioceres reporting persons reduced their direct holdings through repurchase and pledge agreements, but retain a material stake. Bioceres Group Limited, together with its subsidiary Bioceres LLC, reports aggregate beneficial ownership of 12,508,975 ordinary shares, representing 19.9% of Bioceres Crop Solutions Corp.'s outstanding shares based on 62,848,483 shares. The Amendment reports that Shares owned by the Reporting Persons decreased from 12,421,323 to 9,432,896 following repurchase agreements dated September 1, 2022 and September 1, 2023 and pledge agreements dated October 28, 2022, executed to fund payment of financial obligations. 3,076,079 shares remain subject to a shareholders agreement over voting rights. No other plans or transactions were disclosed.
Bioceres Crop Solutions Corp. furnished a Form 6-K to provide investors access to two key documents. First, the company attached a press release announcing its fourth fiscal quarter and full fiscal year 2025 financial and operational results as Exhibit 99.1. Second, it included as Exhibit 99.2 the consolidated financial statements of its subsidiary Rizobacter Argentina S.A. for the fiscal year ended June 30, 2025, as filed with the Argentine securities regulator. This filing mainly serves as a communication vehicle, making these results and subsidiary financial statements available to the market.
Bioceres Crop Solutions Corp. reported that its board and Milen Marinov mutually agreed that he would step down as Chief Commercial Officer, effective August 31, 2025. He also resigned from the company’s board of directors.
The company stated that Mr. Marinov’s departure was not due to any disagreement over operations, policies, or practices. Bioceres has begun a formal process to identify a successor and plans to share further updates when appropriate.
BAF Latam Credit Fund B.V. reports beneficial ownership of 3,461,430 ordinary shares of Bioceres Crop Solutions Corp. (BIOX), representing 5.52% of the class based on the issuer's reported outstanding share count of 62,712,602. The filing states BAF holds sole voting power and sole dispositive power over the disclosed shares.
The statement was submitted on Schedule 13G and includes an Item 10 certification that the securities were not acquired to change or influence control of the issuer, indicating the filer describes the position as passive under the Schedule 13G framework.
Jasper Lake Ventures One LLC and Noah Kolatch report a combined economic interest of 7,382,919 ordinary shares in Bioceres Crop Solutions Corp. (BIOX), representing approximately 10.6% of the outstanding class on the calculation in this filing. That position includes 397,000 Ordinary Shares held directly by Jasper Lake plus the Ordinary Shares issuable upon conversion of a secured guaranteed convertible Note into 6,985,919 Ordinary Shares as of this filing.
The Notes were purchased under a Note Purchase Agreement as part of a $55,000,000 issuance, with Jasper Lake acquiring $33,500,000 in principal. The Notes bore regular interest at 9.00% per year until June 15, 2025 and 15.00% thereafter, mature on August 31, 2027, and are convertible into Ordinary Shares using a Strike Price originally equal to $6.00 subject to customary anti-dilution adjustments and price-based reductions in certain financings. PIK interest accrues and compounds, increasing the Accreted Principal Amount and the number of shares issuable on conversion.
Under an amendment, Noah Kolatch was appointed to the Issuer's Board and the Issuer also appointed Scott Croco and Milen Marinov; replacement-nomination rights for certain directors are described. The Reporting Persons state the acquisition was for investment purposes, note registration rights were granted, and disclose they may engage with management or consider actions including acquiring or disposing of securities, hedging, or proposing strategic alternatives.
Bioceres Group Limited and affiliates trimmed their stake in Bioceres Crop Solutions Corp. (BIOX) in Schedule 13D/A Amendment No. 15 dated 08 Aug 2025. The group’s beneficial ownership fell to 15,497,402 ordinary shares, equal to 24.7 % of BIOX’s 62,848,483 shares outstanding, down from 18,561,323 shares previously reported. The reduction—≈ 6.14 million shares—resulted from open-market sales and enforcement of pledge agreements executed under the New York UCC to satisfy financial obligations.
Breakdown of holdings: Bioceres Group Limited holds 70,785 shares directly and, through subsidiaries, shares voting/dispositive power over 15.4 million. Subsidiaries Bioceres LLC and THEO I SCSp own 14,989,117 (23.8 %) and 437,500 (0.7 %) shares, respectively. Of the total, 3,076,079 shares are subject to a 2019 Shareholders Agreement giving the group shared voting rights.
Key takeaways for investors: (1) Bioceres entities remain BIOX’s largest shareholder but have reduced influence by ~4.8 percentage points; (2) Sale was motivated by obligation settlement, not stated strategic change; (3) No new plans or proposals affecting BIOX were disclosed.